GENERAL INFORMATION
Established:  1995
Ownership:  Private

Core business

Wireless, interactive technology, software and hardware.
Intra-body navigational systems for minimally-invasive medical
procedures in the field of pulmonology.

Employees:  100
Main Markets:  Patients in need of diagnostic bronchoscopy.

Overview

SUPERDIMENSION LTD. has developed the superDimension/Bronchus
system in answer to one of the most critical needs in the field
of pulmonology: minimally invasive access to peripheral lung
locations.

Over 3,000,000 bronchoscopies are performed annually worldwide,
with the majority of target lung lesions situated in the
peripheral areas of the lungs where the bronchoscope itself
cannot reach. Consequently, as much as 65% of diagnostic
bronchoscopies in the lung's periphery fail to reach the target
and must be repeated or replaced with more invasive approaches,
such as CT-guided percutaneous needle biopsy or surgical biopsy.

The superDimension/Bronchus system is set to increase the
effectiveness of bronchoscopy with its new image guided
technology. It overcomes the limitations of traditional
bronchoscopy by extending the reach of the bronchoscope to the
lungs' periphery. It enables accurate and minimally-invasive
navigation anywhere in the lungs, in real-time and on a
three-dimensional roadmap, increasing both the success rate and
applicability of diagnostic bronchoscopy.

The system generates 3-D images from pre-operative CT scans of
the patient's lungs, creating a roadmap of the lungs. This
"roadmap" then tracks the movement and location of a sensor
located at the tip of a dedicated tool that is inserted through
the bronchoscope. The sensor's movements and position are
overlaid in real-time onto the virtual 3D image of the lungs,
alllowing the physician to navigate through the once unreachable
areas of the patient's lungs.

The superDimension/Bronchus system has recently received CE Mark
approval, and is now used in Germany and other European
countries. An FDA submission is in process.